Literature DB >> 11211968

Expression and localisation of IGF-binding protein mRNAs in regenerating rat skeletal muscle.

E Jennische1, C M Hall.   

Abstract

The expression of the insulin-like growth factor-binding proteins (IGFBP) -3, -4, -5 and -6 was investigated in neonatal, in normal adult and in regenerating rat skeletal muscle. Semi-quantification was done by densitometric scannings of Northern blots. The expression of all investigated IGFBPs, with the exception of IGFBP-5, was higher in neonatal than in adult muscle. During postischaemic regeneration the expression of all IGFBPs increased, but with different time schedules. IGFBP-3 increased transiently during the early phase of regeneration, while IGFBP-4, -5 and -6 increased during the later phase of regeneration. In situ hybridisation on regenerating muscle showed that the expression of the various IGFBPs was cell specific; thus, IGFBP 3 was mainly expressed in macrophages, IGFBP-4 in connective tissue, IGFBP-5 in regenerating muscle cells, and IGFBP-6 in muscle cells, connective tissue and endothelium. Ligand blotting, using 125I-IGF-I as the ligand, showed a number of bands ranging between 24 and 44 kDa. Samples from neonatal and regenerating muscle contained much higher levels of all IGFBPs than those from normal adult muscle. An ordered and cell-specific expression of IGFBPs, allowing a strict regulation of IGF actions, is probably necessary to ensure an optimal regeneration process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11211968     DOI: 10.1034/j.1600-0463.2000.d01-24.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  8 in total

1.  Expression of specific IGFBPs is associated with those of the proliferating and differentiating markers in regenerating rat plantaris muscle.

Authors:  Akihiko Yamaguchi; Kunihiro Sakuma; Takahiko Fujikawa; Isao Morita
Journal:  J Physiol Sci       Date:  2012-08-15       Impact factor: 2.781

2.  Age and estrogen-based hormone therapy affect systemic and local IL-6 and IGF-1 pathways in women.

Authors:  Maarit Ahtiainen; Eija Pöllänen; Paula H A Ronkainen; Markku Alen; Jukka Puolakka; Jaakko Kaprio; Sarianna Sipilä; Vuokko Kovanen
Journal:  Age (Dordr)       Date:  2011-08-16

3.  Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice.

Authors:  Jonathan D Schertzer; Stefan M Gehrig; James G Ryall; Gordon S Lynch
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

4.  Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin.

Authors:  Akira Hirata; Satoru Masuda; Tetsuo Tamura; Kazuko Kai; Koichi Ojima; Akiko Fukase; Kazuo Motoyoshi; Keiko Kamakura; Yuko Miyagoe-Suzuki; Shin'ichi Takeda
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

5.  Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting.

Authors:  Calvin L Cole; John F Bachman; Jian Ye; Joseph Murphy; Scott A Gerber; Christopher A Beck; Brendan F Boyce; Gowrishankar Muthukrishnan; Joe V Chakkalakal; Edward M Schwarz; David Linehan
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-05-07       Impact factor: 12.910

6.  αMSH blunts endotoxin-induced MuRF1 and atrogin-1 upregulation in skeletal muscle by modulating NF-κB and Akt/FoxO1 pathway.

Authors:  Ana Isabel Martín; Ana Belén Gómez-SanMiguel; Carolina Gómez-Moreira; María Ángeles Villanúa; Asunción López-Calderón
Journal:  Mediators Inflamm       Date:  2014-09-09       Impact factor: 4.711

7.  High-Methionine Diet Attenuates Severity of Arthritis and Modulates IGF-I Related Gene Expressions in an Adjuvant Arthritis Rats Model.

Authors:  Mingxin Li; Lidong Zhai; Wanfu Wei
Journal:  Mediators Inflamm       Date:  2016-09-25       Impact factor: 4.711

8.  Reversal of deficits in aged skeletal muscle during disuse and recovery in response to treatment with a secrotome product derived from partially differentiated human pluripotent stem cells.

Authors:  Dennis K Fix; Ziad S Mahmassani; Jonathan J Petrocelli; Naomi M M P de Hart; Patrick J Ferrara; Jessie S Painter; Gabriel Nistor; Thomas E Lane; Hans S Keirstead; Micah J Drummond
Journal:  Geroscience       Date:  2021-08-24       Impact factor: 7.713

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.